Description
+ Include: 25 videos + 13 pdfs, size: 6.18 GB
+ Target Audience: cardiologist, family medicine physician
+ Sample video: contact me for sample video
+ Information:
Friday, May 3, 2024, 7:00 AM – 7:00 PM, Sanford Consortium, La Jolla, CA
Precision Cardiovascular Care Symposium:
Transitioning Care from Phenotypes to Genotypes 2024 Hybrid Meeting
Cardiovascular medicine is approaching a pivotal turning point, in which therapies introduced are shifting from those based on phenotype to those that treat the root underlying mechanism (endotype) and, more recently, the genetic cause (genotype). Such changes promise more effective therapies that promise to cure diseases instead of simply slowing down their progress. For this promise to be fulfilled, it will require more than developing new therapeutics -fundamental changes will need to occur in clinical practice, including how we identify at-risk patients, predict their disease trajectory, and monitor the benefit and side effects of new therapeutics.
Symposium objectives:
- Provide an Overview of the Changing Landscape of Cardiovascular Diagnostics and Therapeutics
- Discuss cutting-edge preclinical science in cardiovascular biology.
- Review advances in translational biology, including new biomarker technology.
- Provide a synopsis of current and pending clinical trials in precision cardiology.
Highlighted Topics:
- RNA Biology to Treat Cardiovascular Disease
- AAV Therapy: The Beginning, The End of the Beginning or The End
- Basic Mechanisms Responsible for Cardiac Arrhythmia
- Understanding the Cardiac Inflammatory Milieu and Potential Targets
- Design of Clinical Trials for Rare Cardiac Disorders
- Assessing the Safety and Efficacy of Gene Therapy for Cardiomyopathy
+ Topics:
Connexin43 Restoration Improves Cardiac Function and Survival in Mouse and Human Models of Arrhythmogenic Right Ventricular Dysplasia Cardiomyopathy.mp4
Harnessing Gene Regulatory Networks and Functional Genomics to Investigate Early Human Heart Development.mp4
Session 1 – Cardiomyopathies 1 Dietary linoleic acid supplementation ameliorates cardiomyopathy in Barth syndrome, Xi Fang, PhD.mp4
Session 1 – Cardiomyopathies 1 Mitochondrial Dysfunction in the Failing Heart , Asa Gustafson, PhD.mp4
Session 1 – Cardiomyopathies 1 Mitochondrial Dysfunction in the Failing Heart , Asa Gustafson, PhD.pdf
Session 1 – Cardiomyopathies 1 Overview of Genetic Dilated Cardiomyopathies – Quan Bui, MD.mp4
Session 1 – Cardiomyopathies 1 Overview of Genetic Dilated Cardiomyopathies – Quan Bui, MD.pdf
Session 2 – Advances in Cardiomyopathies From Hypertrophic to Arrhythmogenic Molecular Insights and Novel Therapies for AC, Victoria Parikh, MD.mp4
Session 2 – Advances in Cardiomyopathies From Hypertrophic to Arrhythmogenic Molecular Insights and Novel Therapies for AC, Victoria Parikh, MD.pdf
Session 2 – Advances in Cardiomyopathies From Hypertrophic to Arrhythmogenic Non sarcomeric causes of HCM- ALKP3, Wei Feng, PhD.mp4
Session 2 – Advances in Cardiomyopathies From Hypertrophic to Arrhythmogenic Overview of Arrhythmogenic Cardiomyopathies (AC), Frederick Han, MD.mp4
Session 2 – Advances in Cardiomyopathies From Hypertrophic to Arrhythmogenic Overview of Arrhythmogenic Cardiomyopathies (AC), Frederick Han, MD.pdf
Session 2 – Advances in Cardiomyopathies From Hypertrophic to Arrhythmogenic Overview of Hypertrophic Cardiomyopathy (HCM), Jorge Silva, MD.mp4
Session 2 – Advances in Cardiomyopathies From Hypertrophic to Arrhythmogenic Overview of Hypertrophic Cardiomyopathy (HCM), Jorge Silva, MD.pdf
Session 3 – Vascular Biology and Lipid Disorders Hyperlipidemia Treatment 2024, Harpreet Bhatia, MD, MAS.mp4
Session 3 – Vascular Biology and Lipid Disorders Hyperlipidemia Treatment 2024, Harpreet Bhatia, MD, MAS.pdf
Session 3 – Vascular Biology and Lipid Disorders Lipoprotein(a) – Target for Personalized Prevention of Aortic Stenosis, Calvin Yeang, MD, PhD.mp4
Session 3 – Vascular Biology and Lipid Disorders Lipoprotein(a) – Target for Personalized Prevention of Aortic Stenosis, Calvin Yeang, MD, PhD.pdf
Session 3 – Vascular Biology and Lipid Disorders ROUND TABLE 1 Novel Platforms for Delivering Precision Medicines for Cardiovascular Disease.mp4
Session 4 – Clinical Trial Design Building Better Clinical Trial Using Disease Progression Models, Joe Marion, PhD.mp4
Session 4 – Clinical Trial Design Building Better Clinical Trial Using Disease Progression Models, Joe Marion, PhD.pdf
Session 4 – Clinical Trial Design Designing Clinical Trials for Patients with Hypertrophic Cardiomyopathy, Dan Jacoby, MD.mp4
Session 4 – Clinical Trial Design Intro to rare disease clinical trial design, Kimberly Hong, MD.mp4
Session 4 – Clinical Trial Design Intro to rare disease clinical trial design, Kimberly Hong, MD.pdf
Session 4 – Clinical Trial Design Regulatory perspective on facilitating clinical trials for rare disease therapeutics, Peter Marks MD, PhD.mp4
Session 5 – Novel Insights and Tools for Treating Genetic Disease Engineered RNA-targeting approaches for myotonic dystrophy, Gene Yeo, PhD.mp4
Session 5 – Novel Insights and Tools for Treating Genetic Disease Engineered RNA-targeting approaches for myotonic dystrophy, Gene Yeo, PhD.pdf
Session 5 – Novel Insights and Tools for Treating Genetic Disease Immunology, Inflammation and Heart Failure, Kevin King MD, PhD.mp4
Session 5 – Novel Insights and Tools for Treating Genetic Disease Round Table 2 Abstract Presentations.mp4
Session 5 – Novel Insights and Tools for Treating Genetic Disease Unraveling the Pathogenesis of Cardiac Disease Using Single Cell Sequencing, Neil Chi,MD, PhD.mp4
Session 6 Cardiac Amyloidosis Diagnosing and Prognosticating Cardiac Amyloidosis, Quan Bui, MD.mp4
Session 6 Cardiac Amyloidosis Diagnosing and Prognosticating Cardiac Amyloidosis, Quan Bui, MD.pdf
Session 6 Cardiac Amyloidosis The Therapeutic Landscape of Cardiac Amyloidosis, Marcus Anthony Urey, MD.mp4
Session 6 Cardiac Amyloidosis The Therapeutic Landscape of Cardiac Amyloidosis, Marcus Anthony Urey, MD.pdf
Session 7 Biomarkers, Imaging, and Heart Disease Bedside to Bench Approach to Drug Development, Eric Adler, MD.mp4
Session 7 Biomarkers, Imaging, and Heart Disease Myocarditis Clinical Presentations and New Trials, Benjamin Cruz, MD.mp4
Session 7 Biomarkers, Imaging, and Heart Disease Myocarditis Clinical Presentations and New Trials, Benjamin Cruz, MD.pdf
Session 7 Biomarkers, Imaging, and Heart Disease Novel Biomarkers for Profiling Cardiovascular Risk in Kidney Disease, Nicholas Wettersten, MD.mp4
Reviews
There are no reviews yet.